Patient-derived Xenografts Reveal that Intraductal Carcinoma of the Prostate Is a Prominent Pathology in BRCA2 Mutation Carriers with Prostate Cancer and Correlates with Poor PrognosisGail P. Risbridger, Damien Bolton, Heather Thorne et al.|European Urology|2014Cited by 137
Decreased Prostate Cancer-Specific Survival of Men with<i>BRCA</i>2 Mutations from Multiple Breast Cancer FamiliesHeather Thorne, Damien Bolton, Amber J. Willems et al.|Cancer Prevention Research|2011Cited by 112